Skip to main content
SpringerLink
Log in

New therapeutic strategies for NSCLC in Italy: improved survival, higher cost

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Buja A, et al. Non-Small-Cell Lung Cancer: Real-World Cost Consequence Analysis. JCO Oncology Practice : OP2000863, 7 Apr 2021. Available from: URL: http://doi.org/10.1200/OP.20.00863

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

New therapeutic strategies for NSCLC in Italy: improved survival, higher cost. PharmacoEcon Outcomes News 876, 22 (2021). https://doi.org/10.1007/s40274-021-7636-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7636-9

Search

Navigation